| Literature DB >> 35911841 |
Ruixia Chang1, Chunan Li1, Haiqin Qi1, Ya Zhang1, Jianduan Zhang1.
Abstract
Objective: To examine the birth and health outcomes of children migrating with parents internationally and domestically, and to identify whether the healthy migration effect exist in migrant children.Entities:
Keywords: birth outcomes; health outcomes; healthy migration effect; meta-analysis; migrant children
Year: 2022 PMID: 35911841 PMCID: PMC9326113 DOI: 10.3389/fped.2022.810150
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
Figure 1PRISMA flow diagram. *Some studies included more than one outcome.
Characteristics of the included studies (N = 98).
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| Kana et al. ( | 2019 | Portugal | CS | — | 386 | 8,171 | Birth outcome (LBW, Preterm birth) | LBW: birth weight <2,500 g |
| Gillet et al. ( | 2014 | Belgium | CS | — | 129,200 | 261,566 | Birth outcome (LBW, Preterm birth) Death (Neonatal death, Post-neonatal death, Infant death) | LBW: birth weight <2,500 g |
| Cebolla-Boado and Salazar ( | 2016 | Spain | CS | — | 71,758 | 287,153 | Birth outcome (LBW, HBW) | LBW: birth weight ≤ 2,500 g |
| Forna et al. ( | 2003 | US | Cohort | — | 13,465 | 36,439 | Birth outcome (LBW, Preterm birth) | LBW: birth weight <2,500 g |
| Sandra et al. ( | 2015 | Spain | CS | — | 72,567 | 599,660 | Birth outcome (LBW, HBW) | LBW: birth weight <2,500 g |
| Besharat et al. ( | 2014 | Sweden | Cohort | — | 336 | 2,181 | Birth outcome (LBW, HBW, Preterm) | LBW: birth weight <2,500 g |
| Racape et al. ( | 2016 | Belgium | CS | — | 334,150 | 1,029,471 | Birth outcome (LBW) Death (Perinatal death) | LBW: birth weight <2,500 g |
| Lehti et al. ( | 2013 | Finland | CC | — | 347 | 5,300 | Birth outcome (LBW, Preterm) Mental health (ASD) | LBW: birth weight <2,500 g |
| Milewski and Peters ( | 2014 | Germany | Cohort | — | 427 | 1,214 | Birth outcome (LBW, HBW) | LBW: birth weight <2,500 g |
| Ratnasiri et al. ( | 2020 | US | CS | — | 446,724 | 611,253 | Birth outcome (LBW, Preterm birth) Death (Neonatal death, Post-neonatal death) | LBW: birth weight <2,500 g |
| Hessol and Fuentes-Afflick ( | 2014 | US | CS | — | 410,284 | 231,190 | Birth outcome (LBW, HBW, Preterm birth) | LBW: birth weight <2,500 g |
| Castello et al. ( | 2012 | Spain | CS | — | 5,926 | 15,782 | Birth outcome (LBW, Preterm birth) | LBW: birth weight <2,500 g |
| Juarez and Revuelta-Eugercios ( | 2014 | Spain | CS | — | 323,856 | 1,061,924 | Birth outcome (LBW, HBW, Preterm birth) | LBW: birth weight <2,500 g |
| Fuster et al. ( | 2014 | Spain | CS | — | 412,906 | 1,874,913 | Birth outcome (LBW, preterm) Death (fetal death) | LBW: birth weight <2,500 g |
| Racape et al. ( | 2010 | Belgium | Cohort | — | 56,061 | 74,767 | Birth outcome (LBW, Preterm birth) Death (Fetal mortality, Neonatal mortality, Post-neonatal mortality) | LBW: birth weight <2,500 g |
| Glick et al. ( | 2009 | US | Cohort | — | 2,300 | 7,300 | Birth outcome (LBW) | LBW: birth weight <2,500 g |
| Farre ( | 2013 | Spain | CS | — | 233,518 | 1,773,102 | Birth outcome (LBW, Preterm birth) Death (Perinatal death) | LBW: birth weight <2,500 g |
| Nancy et al. ( | 2015 | US | CS | — | 305 | 1,361 | Birth outcome (LBW) | LBW: Birth weight <2,500 g |
| Lehti et al. ( | 2016 | Finland | CC | — | 1,730 | 47,803 | Birth outcome (LBW, Preterm) Mental health (ADHD) | LBW: birth weight <2,500 g |
| Gissler et al. ( | 2003 | Sweden | CS | — | 34,357 | 110,008 | Birth outcome (LBW) Death (Fetal death, Neonatal death, Perinatal death) | LBW: birth weight <2,500 g |
| Madan et al. ( | 2006 | US | CS | — | 2,418,501 | 4,005,671 | Birth outcome (LBW) Death (Neonatal death, Post-neonatal death) | LBW: birth weight <2,500 g |
| Auger et al. ( | 2008 | Canada | CS | — | 43,396 | 54,954 | Birth outcome (LBW, Preterm birth) | LBW: birth weight <2,500 g |
| Bastola et al. ( | 2020 | Finland | CS | — | 31,454 | 350,548 | Birth outcome (LBW, HBW, Preterm birth) Death (Post-neonatal death, Neonatal death, Fetal death) | LBW: birth weight <2,500 g |
| Marcon et al. ( | 2011 | Italy | CS | 3–14 years | 641 | 2,980 | Birth outcome (LBW, HBW) Physical health (Pneumonia, Eczema) | LBW: birth weight <2,500 g |
| Besharat Pour et al. ( | 2017 | Sweden | Cohort | — | 299 | 1,979 | Birth outcome (HBW, Preterm birth) | HBW: Birth weight≥4,000 g |
| Reeske et al. ( | 2013 | Germany | Cohort | — | 384 | 903 | Birth outcome (HBW) | HBW: Birth weight≥4,000 g |
| Choi et al. ( | 2019 | Australia | Cohort | — | 601,299 | 1,735,724 | Death (Neonatal death, Fetal death) Birth outcome (Preterm birth) | Death <28 days among livebirths |
| Essen et al. ( | 2000 | Sweden | CS | — | 5,211 | 10,784 | Birth outcome (Preterm birth) Death (Perinatal death) | Preterm birth: Gestational age <37 weeks |
| Vik et al. ( | 2019 | Norway | CS | — | 198,520 | 115,6444 | Death (fetal death) Birth outcome (Preterm birth) | Stillbirth: a pregnancy loss at ≥22weeks of gestation or with a birthweight ≥500 g if data on gestational age were missing |
| Anil Kumar ( | 2016 | India | CS | 0–4 years | 11,327 | 2,488 | Nutrition (Overweight/ | Overweight/obesity: BMI scores |
| Liu et al. ( | 2016 | China | CS | 5–12 years | 3,057 | 6,860 | Nutrition (Overweight/ | World Health Organization reference 2007 |
| Ji et al. ( | 2016 | China | CS | 10.7 ± 0.94 years | 991 | 650 | Nutrition (Overweight/ | Overweight/obesity: based on cutoff of the Working Group on Obesity of China |
| Lin et al. ( | 2011 | Taiwan | CS | 7–12 years | 157 | 519 | Nutrition (Overweight) Mental health (Depression) | Overweight: BMI≥85th percentile based on Department of Health criteria, Taiwan, ROC. |
| De Carli et al. ( | 2018 | Italy | CS | 11–12 years | 353 | 847 | Nutrition (Overweight/obesity, Underweight) | The International Obesity Task Force cut-offs |
| Zulfiqar et al. ( | 2018 | Australia | Cohort | 2–11 years | 1,799 | 2,434 | Nutrition (Overweight/obesity) | The International Obesity Task Force standard |
| Maximova et al. ( | 2011 | Canada | CS | 11.2 ± 1.1 years | 5,261 | 1,131 | Nutrition (Overweight/obesity) | The International Obesity Task Force standard |
| Lindstrom et al. ( | 2014 | Sweden | CS | 15–16 years | 2,423 | 7,195 | Nutrition (Overweight/obesity) Physical health (Asthma) Substance use (Tobacco use) | Boy: overweight/obesity 23.29–28.29/28.30; girl: 23.94–29.10/29.11 |
| Esteban-Gonzalo et al. ( | 2014 | Spain | CS | 13–17 years | 335 | 1,742 | Nutrition (Overweight/ obesity) Mental health (Depression) Substance use (Tobacco use) | Overweight/obesity: using the BMI age- and gender-specific cut-offs proposed by Cole et al.) 27, Depression: self-reported medical diagnosis of depression |
| Besharat Pour et al. ( | 2014 | Sweden | Cohort | 8 years | 561 | 2,028 | Nutrition (Overweight/obesity) | Age- and sex-adjusted BMI corresponding to adult BMI ≥ 25 kg/m2 |
| Furthner et al. ( | 2017 | Austria | CS | 13.8 years | 827 | 2,103 | Nutrition (Overweight/Obesity) | Overweight: 85th−95th BMI percentile |
| Burgi et al. ( | 2010 | Switzerland | CS | 5.1 ± 0.60 years | 391 | 151 | Nutrition (Overweight/obesity) | International Obesity Task Force (IOTF) |
| Iguacel et al. ( | 2018 | Spain | Cohort | 2.0–9.9 years | 1,156 | 7,427 | Nutrition (Overweight/Obesity) | extended International Obesity Task Force criteria |
| Khanolkar et al. ( | 2013 | Sweden | CS | 4–5 years | 1,286 | 9,342 | Nutrition (Overweight/Obesity) | International Obesity Task Force |
| Thi et al. ( | 2019 | Germany | CS | 5–7 years | 1,080 | 2,623 | Nutrition (Overweight/Obesity) | BMI is above the 90th percentile according to the BMI reference systems of Kromeyer-Hauschild |
| Will et al. ( | 2005 | Germany | CS | 6–7 years | 258 | 265 | Nutrition (Overweight/Obesity) | The International Obesity Task Force, using international reference values based on data from six countries |
| Zhou et al. ( | 2018 | Germany | CS | — | 19,245 | 31,441 | Nutrition (Overweight/obesity) | BMI≥90th percentile based on the German national reference |
| Méroc et al. ( | 2019 | Belgium | CS | 10–11 years | 2,319 | 553 | Nutrition (Overweight/obesity) | The International Obesity Task Force standard |
| Labree et al. ( | 2015 | Finland | CS | 8–9 years | 397 | 1,546 | Nutrition (Overweight/Obesity, Underweight) | The International Obesity Task Force standard |
|
|
|
|
|
|
|
|
|
|
| Brettschneider et al. ( | 2011 | Germany | CS | 11–17 years | 518 | 2,949 | Nutrition (Overweight) | BMI >90th percentile based on the national German reference |
| Vorwieger et al. ( | 2018 | Germany | CS | 7.57 ± 0.42 years | 245 | 508 | Nutrition (Abdominal obesity) | WHtR ≥0.5 |
| Nagel et al. ( | 2009 | Germany | CS | 7.6 ± 0.4 years | 317 | 762 | Nutrition (Overweight/obesity) | The International Obesity Task Force standard |
| Beyerlein et al. ( | 2014 | Germany | CS | 3–17 years | 474 | 8,507 | Nutrition (Overweight) | International Obesity Task Force (IOTF) |
| Prusty and Keshri ( | 2015 | India | CS | 0–59 months | 13,220 | 5,617 | Nutrition (Underweight) | WFA-Z < -2SD |
| Saunders et al. ( | 2016 | Canada | CS | 12–72 months | 1,244 | 1,268 | Nutrition (Anemia) | Hemoglobin level <110 g/L (WHO recommendation) |
| Hu et al. ( | 2014 | China | CS | 6–23 months | 667 | 321 | Nutrition (Anemia) | Hemoglobin level <110 g/L (WHO recommendation) |
| Julihn et al. ( | 2010 | Sweden | Cohort | 13–19 years | 5,134 | 10,404 | Physical health (Caries experience) | Clinical examination of DMFT |
| Christensen et al. ( | 2010 | Denmark | CS | 5–15 years | 3,571 | 9,058 | Physical health (Caries experience) | Clinical examination of DMFT |
| van Meijeren et al. ( | 2019 | Netherlands | Cohort | 9 years | 611 | 2,510 | Physical health (Caries experience) | Clinical examination of DMFT |
| Ferrazzano et al. ( | 2019 | Italy | CS | 12–14 years | 183 | 370 | Physical health (Caries experience) | Clinical examination of DMFT |
| van der Tas et al. ( | 2016 | Netherlands | CS | 4.96 years | 1,403 | 2,957 | Physical health (Caries experience) | Clinical examination of DMFT |
| Almerich-Silla and Montiel-Company ( | 2007 | Spain | CS | 12–15 years | 54 | 825 | Physical health (Caries experience) | Clinical examination of DMFT |
| Bissar et al. ( | 2014 | Germany | CS | 4.1 ± 0.8 years | 265 | 698 | Physical health (Caries experience) | Clinical examination of DMFT |
| Baggio et al. ( | 2015 | Switzerland | CS | 36–71 months | 398 | 457 | Physical health (Caries experience) | Clinical examination of DMFT |
| Bardin et al. ( | 2019 | Italy | Cohort | 0–14 years | 21,817 | 191,345 | Physical health (Gastroenteritis, Pneumonia, Asthma) | ICD-9 |
| Charania et al. ( | 2020 | New Zealand | CS | 0–5 years | 125,511 | 567,408 | Physical health (Gastroenteritis, Pneumonia) | Hospitalization event |
| Li et al. ( | 2019 | China | CS | 12–15 years | 3,477 | 2,213 | Physical health (Pneumonia, Asthma, Eczema) | Physician-diagnosed |
| Migliore et al. ( | 2007 | Italy | CS | 6–7/13–14 years | 1,012 | 28,293 | Physical health (Pneumonia, Asthma) | Self-reported questionnaire |
| Keet et al. ( | 2012 | US | CS | 11.4 years | 341 | 3,209 | Physical health (Asthma, Eczema, Food allergy) | Physician-diagnosed |
| Svendsen et al. ( | 2009 | US | CS | 9–11 years | 2,026 | 4,370 | Physical health (Asthma, Food allergy) | Physician-diagnosed |
| Radhakrishnan et al. ( | 2019 | Canada | Cohort | 0–18 years | 422,305 | 968,256 | Physical health (Asthma) | ICES (institute for clinical Evaluation Sciences) database |
| Apfelbacher et al. ( | 2011 | Germany | CS | 0–17 years | 2,550 | 14,640 | Physical health (Eczema) | Physician-diagnosed |
| Koplin et al. ( | 2014 | Australia | Cohort | 11–15 months | 535 | 3,023 | Physical health (Food allergy) | Food allergy to egg, peanut or sesame was defined as a positive oral food challenge in sensitized infants (SPT wheal ≥ 2 mm or specific IgE ≥ 0.35 ku/l) |
| Ramadhani et al. ( | 2009 | US | CC | — | 575 | 539 | Physical health (Heart defects, Neural tube defect) | Surveillance registries system |
| Kang et al. ( | 2016 | China | CS | 6–13 years | 325,940 | 214,634 | Physical health (Heart defects) | Clinical cardiovascular examination |
| Velie et al. ( | 2006 | US | CC | — | 265 | 606 | Physical health (Neural tube defect) | California Birth Defects Monitoring system |
| Kim et al. ( | 2018 | US | CS | 8–18 years | 1,013 | 1,361 | Mental health (Depression) | MFQ (Mood and Feelings Questionnaire) |
| Fuhrmann et al. ( | 2014 | US | CS | 6.2 ± 0.4 years | 118 | 535 | Mental health (Depression) | PFC (Preschool Feelings Checklist) |
| Adriaanse et al. ( | 2014 | Netherlands | CS | 12.9 ± 1.8 years | 576 | 702 | Mental health | The Strengths and Difficulties Questionnaire (SDQ) |
| Wang et al. ( | 2017 | China | CS | 11.04 ± 0.04 years | 731 | 451 | Mental health | SDQ |
| van der Ven et al. ( | 2013 | Netherlands | Cohort | 26,599 | 80,354 | Mental health (ASD) | DSM-IV diagnosis | |
| Wandell et al. ( | 2020 | Sweden | Cohort | <18 years | 1,149,504 | 2,873,645 | Mental health (ASD) | DSM-IV diagnosis |
| Magnusson et al. ( | 2012 | Sweden | CC | 0–17 years | 9,396 | 34,567 | Mental health (ASD) | DSM-IV diagnosis |
| Weiser et al. ( | 2008 | Israel | CS | 7.7 ± 3.7 years | 639,203 | 22,589 | Mental health (Schizophrenia) | ICD-9 and ICD-10 |
| Hjern et al. ( | 2004 | Sweden | CS | — | 87,988 | 1,056,225 | Mental health (Schizophrenia) | ICD-9/ICD-10 |
| Pedersen et al. ( | 2012 | Denmark | Cohort | — | 202 | 1,639 | Mental health (Schizophrenia) | ICD-10 |
| Lu et al. ( | 2020 | China | CS | 13.67 ± 1.52 years | 1,858 | 2,359 | Mental health (Suicide attempt) | Self-injurious thoughts and behaviors (SITBs) |
| Vazsonyi et al. ( | 2017 | Switzerland | CS | 17.85 ± 1.21years | 741 | 6,546 | Mental health (Suicide attempts) | Self-reported questionnaire |
| Villadsen et al. ( | 2010 | Northern Europe | CS | — | 265,135 | 9,649,736 | Death (Neonatal mortality, Fetal death) | Death within 0–27 days of birth |
| Barona-Vilar et al. ( | 2014 | Spain | CS | — | 40,834 | 162,043 | Death (Perinatal death) | The number of fetal and neonatal deaths per 1,000 total births |
| Vang ( | 2016 | Canada | CS | — | 514,247 | 2,856,394 | Death (Post-neonatal death, Neonatal death) | Neonatal death: 0 to 27 days and Post-neonatal death: 28 to 364 days |
| Rosenberg et al. ( | 2002 | US | CS | — | 72,293 | 130,681 | Death (Infant death) | Death before first birthday |
| Landale et al. ( | 2006 | US | CS | — | 4,342 | 715 | Death (Infant death) | Died before reaching the age of 1 year |
| Troe et al. ( | 2007 | Netherlands | CS | — | 30,331 | 3,838 | Death (Infant death) | Died before reaching the age of 1 year |
| Abebe et al. ( | 2015 | Norway | CS | 14–17 years | 2,932 | 8,002 | Substance use (Cannabis use, Tobacco use, Alcohol use) | Self-report questionnaire |
| Slonim-Nevo et al. ( | 2006 | Russia | CS | 15–17 years | 396 | 127 | Substance use (Tobacco use, Alcohol use) | Self-report questionnaire |
| Donath et al. ( | 2016 | Germany | CS | 14.88 ± 0.74 years | 2,277 | 7,235 | Substance use (Cannabis use) | Self-report questionnaire |
CS, cross-sectional; CC, case-control; LBW, low birthweight; HBW, high birthweight; ADHD, attention deficit hyperactivity disorder; ASD, autistic spectrum disorder. — represents the data cannot be obtained
Figure 2Forest plot of ORs for health outcomes. (A) Birth outcome. (B) Nutrition. (C) Physical health. (D) Mental health. (E) Death. (F) Substance use.
The subgroup analyses by study region.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
|
| 0.95(0.90, 1.02) | 68.5% | 0.84 (0.75, 0.94) | 76.7 |
| LBW | 0.89 (0.84, 0.94) | 73.2% | 0.83 (0.65, 1.05) | 79.8 |
| HBW | 1.11 (0.85,1.45) | 69.3% | — | |
| Preterm birth | 0.96 (0.88, 1.04) | 75.0% | 0.81 (0.71, 0.92) | 80.4 |
|
| 1.51 (1.29, 1.78) | 71.1% | 0.98 (0.81, 1.17) | 81.7% |
| Overweight/obesity | 1.62 (1.39, 1.90) | 68.8% | 0.86 (0.68, 1.09) | 80.3% |
| Underweight | 0.76 (0.57, 1.01) | 0% | — | |
| Anemia | — | 1.37 (1.01, 1.87) | 73.6% | |
|
| 1.48 (1.02, 2.14) | 79.1% | 1.20 (1.03, 1.41) | 74.1% |
| Oral disease | 2.59 (2.10, 3.20) | 62.1% | — | |
| Gastrointestinal disease | — | 1.48 (0.94, 2.34) | 86.5% | |
| Respiratory disease | 0.93 (0.57, 1.54) | 78.2% | 0.85 (0.57, 1.27) | 77.4% |
| Allergic disease | 0.62 (0.51, 0.76) | 0% | 1.30 (0.77, 2.19) | 80.7% |
| Congenital disease | — | 1.32 (0.98, 1.78) | 81.1% | |
|
| 1.17 (0.88, 1.57) | 68.4% | 1.32 (1.14, 1.52) | 49.5% |
| Depression | — | 1.17 (1.09, 1.26) | 0% | |
| ADHD | 0.73 (0.16, 3.38) | 78.8% | — | |
| ASD | 0.93 (0.78, 1.12) | 71.8% | — | |
| Schizophrenia | 1.90 (1.75, 2.06) | 0% | — | |
| Suicide attempt | — | — | ||
|
| 1.23 (1.13, 1.34) | 70.2% | 0.97 (0.87, 1.09) | 75.9% |
| Fetal death | 1.33 (1.12, 1.34) | 67.3% | 1.07 (0.96, 1.19) | 67.45 |
| Perinatal death | 1.25 (1.04, 1.50) | 60.0% | — | |
| Neonatal death | 1.20 (1.06, 1.35) | 30.7% | 1.06 (1.02, 1.10) | 0% |
| Post-neonatal death | 1.00 (0.80, 1.25) | 0% | 0.88 (0.66, 1.16) | 66.4% |
| Infant death | 1.08 (0.82, 1.41) | 42.3% | 0.83 (0.53, 1.29) | 74.3% |
|
| 0.83 (0.54, 1.27) | 78.5% | — | |
LBW, low birth weight; HBW, high birth weight; ADHD, attention deficit hyperactivity disorder; ASD, autistic spectrum disorder. “—” indicate the studies included in the specific outcome no more than one. The pooled OR with 95%CI for the risk of health outcome among subgroup using random-effects model.